Related Experiment Video
Updated: Mar 31, 2026
08:36
Chitosan/Interfering RNA Nanoparticle Mediated Gene Silencing in Disease Vector Mosquito Larvae
Published on: March 25, 2015
15.2K
Chitosan Nanoparticles for SiRNA Delivery In Vitro
Héloïse Ragelle1,2, Kevin Vanvarenberg1, Gaëlle Vandermeulen1
1Louvain Drug Research Institute, Advanced Drug Delivery and Biomaterials, Université catholique de Louvain, 1200, Brussels, Belgium.
Methods in Molecular Biology (Clifton, N.J.)
|October 17, 2015
Summary
Researchers developed an efficient method for delivering small interfering RNAs (siRNAs) using chitosan nanoparticles. This technique enhances gene silencing efficacy while minimizing cytotoxicity, offering a promising therapeutic approach.
Area of Science:
- Biotechnology
- Nanomedicine
- Gene Therapy
Background:
- RNA interference (RNAi) utilizing small interfering RNAs (siRNAs) is a powerful tool for gene silencing and disease treatment.
- Challenges in siRNA delivery include instability and poor cell membrane permeability, hindering therapeutic applications.
- Polymeric nanocarriers, particularly chitosan, show promise for protecting and delivering siRNAs due to their biocompatibility and charge properties.
Purpose of the Study:
- To develop an optimized method for preparing siRNA/chitosan nanoparticles.
- To achieve high gene silencing efficiency with reduced cytotoxicity.
- To overcome the limitations of traditional chitosan-based siRNA delivery systems.
Main Methods:
- Utilizing the ionic gelation technique to form siRNA/chitosan nanoparticles.
- Characterizing the physicochemical properties of the nanoparticles.
- Evaluating gene silencing efficacy and cytotoxicity in relevant cellular models.
Main Results:
- Successfully prepared siRNA/chitosan nanoparticles with high encapsulation efficiency.
- Demonstrated significant gene silencing activity in mammalian cells.
- Observed low levels of cytotoxicity, indicating a favorable safety profile.
Conclusions:
- The ionic gelation method provides an effective strategy for developing advanced siRNA/chitosan nanoparticles.
- This approach enhances siRNA delivery, leading to potent gene silencing with minimal adverse effects.
- These findings support the potential of chitosan nanoparticles as a viable platform for RNAi-based therapeutics.
Related Concept Videos
02:30siRNA - Small Interfering RNAs
19.0K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
19.0K
02:15Experimental RNAi
8.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.3K
01:23RNA Interference
28.6K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.6K